Key statistics dashboard for Corcept Therapeutics Incorporated (CORT). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily.
Stock Data
| Price | $122.03 |
| Market Cap | $13.2B |
| Enterprise Value | $12.48B |
| Beta | 0.25 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | 234.67 |
| Price / Book | 18.22 |
| P/S | 15.88 |
| EV/EBITDA | 433.39 |
| EV/Sales | 15.02 |
| EV/FCF | 116.69 |
| P/FCF | 123.37 |
| Earnings Yield | 0.45% |
| FCF Yield | 0.85% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 98.30% |
| EBIT Margin | 3.17% |
| EBITDA Margin | 3.47% |
| Operating Margin | 0.77% |
| Net Margin | 6.61% |
| Return on Equity | 8.37% |
| Return on Assets | 6.18% |
| Return on Invested Capital | 0.87% |
| Return on Capital Employed | 0.87% |
Financial Health
| Current Ratio | 2.86 |
| Quick Ratio | 2.77 |
| Cash Ratio | 0.72 |
| Debt / Equity | 0.01 |
| Debt / Assets | 1.06% |
| Net Debt / EBITDA | -3.53 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 14.11 |
Per-Share Data
| Revenue per share | 7.88 |
| Book Value per share | 6.70 |
| Cash per share | 2.92 |
| FCF per share | 1.01 |
| Tangible Book Value per share | 6.70 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 14 |
| Hold | 9 |
| Sell | 3 |
| Strong Sell | 0 |
| Total analysts | 26 |
| Avg rating (1-5) | 0.42 |
Related companies: ABVX · AXSM · CAI · CYTK · HALO · JAZZ · MRUS
Explore sector: Healthcare · Medical - Pharmaceuticals
More sections of CORT: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks